CBER’s Marks Says US FDA’s Rare Disease Work Expected To Win Trump Administration Support

 
• By Sue Sutter
  
Windsock
The FDA's Peter Marks hopes the support for rare disease drug development continues. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Cell & Gene Therapies

More from Rare Diseases